Join us for the Alliance for Regenerative Medicine’s 10th Annual Cell & Gene Therapies State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This event – which is free and open to the public – will include ARM’s annual yearly update on the sector’s progress, as well as two panels featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in 2020. With an anticipated audience of over 500, this session is the largest cell and gene therapy-focused event taking place during JP Morgan week.
Janet Lambert, CEO, Alliance for Regenerative Medicine
Usman “Oz” Azam, President & CEO, Tmunity Therapeutics (moderator)
Claudia Mitchell, Senior VP, Product & Portfolio Strategy, Astellas
Samarth Kulkarni, CEO, CRISPR
Pascal Touchon, CEO, Atara Biotherapeutics
Matthew Kane, Co-Founder and CEO, Precision BioSciences
Timothy Miller, President & CEO, Gene Therapy Newco (moderator)
Laurence Cooper, CEO, Ziopharm
Emile Nuwaysir, President & CEO, BlueRock Therapeutics
Tim Lu, Co-Founder and CEO, Senti Bio
Shelia Mikhail, CEO, AskBio
Couldn’t attend this year’s Cell & Gene Therapies State of the Industry Briefing in-person or looking to have a copy of the slides to reference again? View the full webcast below and download the 2019 Industry Update PPT presentation.
To see all three of the video options click on the horizontal bars in the upper left corner.
55 Cyril Magnin St.
San Francisco, CA 94102
Over 500 of the cell and gene therapy field’s top stakeholders including company founders, C-level business executives, investors, media, patient advocates and academic leaders interested in learning more on the sector’s recent advances and outlook for the industry in the coming year.
